Exact Sciences (EXAS) Shares Outstanding (Diluted Average) (2010 - 2025)

Exact Sciences (EXAS) has 10 years of Shares Outstanding (Diluted Average) data on file, last reported at $188.7 million in Q4 2025.

• Shares Outstanding (Diluted Average) for Q4 2025 came in at $188.7 million, up 2.44% year-over-year; the trailing twelve-month figure through Dec 2025 was $188.7 million (up 2.44% YoY), and the FY2025 annual result was $188.7 million, up 2.44% from the prior year.
• Shares Outstanding (Diluted Average) held at $188.7 million in Q4 2025 per EXAS's latest filing, from $188.3 million in the prior quarter.
• Over five years, Shares Outstanding (Diluted Average) peaked at $188.7 million in Q4 2025 and troughed at $169.4 million in Q1 2021.
• A 5-year average of $179.7 million and a median of $180.2 million in 2023 frame the typical range for Shares Outstanding (Diluted Average).
• The sharpest annual moves came in 2021 and 2024: Shares Outstanding (Diluted Average) climbed 14.53% in 2021, then advanced 0.39% in 2024.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $171.3 million in 2021, then gained by 2.92% to $176.4 million in 2022, then advanced by 2.15% to $180.1 million in 2023, then increased by 2.25% to $184.2 million in 2024, then rose by 2.44% to $188.7 million in 2025.
• Business Quant data shows EXAS's Shares Outstanding (Diluted Average) at $188.7 million in Q4 2025, $188.3 million in Q3 2025, and $187.9 million in Q2 2025.